Setbacks in Blood Substitutes Research and Development: A Biochemical Perspective

Clinics in Laboratory Medicine

Volumn 30, Issue 2, 2010, Pages 381-389

  Alayash, Abdu I ^a,b  

^a Division of Hematology   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Blood substitutes; Hemoglobin toxicity; Oxygen transport

Indexed keywords

BLOOD SUBSTITUTE; HAPTOGLOBIN; HEME; HEMOGLOBIN A; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADVERSE OUTCOME; BIOLOGICAL ACTIVITY; BLOOD CHEMISTRY; BLOOD TRANSFUSION; CHEMICAL STRUCTURE; CYTOTOXICITY; DNA MODIFICATION; EXCHANGE BLOOD TRANSFUSION; GENE TECHNOLOGY; HEMOGLOBIN ANALYSIS; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; OXYGEN AFFINITY; PRIORITY JOURNAL; REVIEW; SAFETY;

ANIMALS; BIOENGINEERING; BLOOD SUBSTITUTES; ERYTHROCYTES; HEMOGLOBINS; HUMANS; OXYGEN;

EID: 77953353898     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.02.009     Document Type: Review

References (23)

1. Winslow R.M. Red cell substitutes. Semin Hematol 2007, 44:51-59.
2. Silverman T.A., Weiskopf R.B. Hemoglobin-based oxygen carriers. current status and future direction. Anesthesiology 2009, 111:946-963.
3. Alayash A.I. Oxygen therapeutics: can we tame haemoglobin?. Nat Rev Drug Discov 2004, 3:152-159.
4. Buehler P.W., Vallelian F., Mikolajczyk M.G., et al. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. Antioxid Redox Signal 2008, 10:1449-1462.
5. Privalle C., Talarico T., Keng T., et al. Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock. Free Radic Biol Med 2000, 28:1507-1517.
6. Adamson J.G., Moore C. Hemolink, an O-raffinose crosslinked hemoglobin based oxygen carrier. Blood substitutes: principles, methods, products and clinical trials 1998, 62-79. Karger, Basel (Switzerland). T.M.S. Change (Ed.).
7. Looker D., Abbott-Brown D., Cozart P., et al. human recombinant haemoglobin designed for use as a blood substitute. Nature 1992, 356:258-260.
8. Jia Y., Ramasamy S., Wood F., et al. Crosslinking with O-raffinose lowers oxygen affinity and stabilizes haemoglobin in a non0-cooperative T-state. Biochem J 2004, 384:367-375.
9. Boykins R.A., Buehler P.W., Jia Y., et al. O-raffinose cross-linked hemoglobin lacks site specific chemistry in the central cavity: structural and functional consequences of beta93cys modification proteins, structure, function and informatics. Proteins 2005, 59:840-855.
10. Buehler P.W., Boykins R.A., Jia Y., et al. Structural and functional characterization of glutaraldehyde polymerized bovine hemoglobin and its isolated fractions. Anal Chem 2005, 77:3466-3478.
11. Buehler P.W., Boykins R.A., Norris S., et al. Chemical characterization of diaspirin cross-linked hemoglobin polymerized with ploy (ethylene glycol). Anal Chem 2006, 78:4634-4641.
12. Vandergrift K.D., Winslow R.M. Hemopsan: design, principles for a new class of oxygen therapeutics. Artif Organs 2009, 33:133-138.
13. Yeh L.H., Alayash A.I. Effects of cell-free hemoglobin on hypoxia inducible factor (HIF-1alpha) and heme oxygenase (HO-1) expression in endothelial cells subjected to hypoxia. Antioxid Redox Signal 2004, 6:944-953.
14. Buehler P.W., D'Agnillo F., Hoffman V., et al. Effects of endogenous ascorbate on oxidation, oxygenation and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rats and guinea pigs. J Pharmacol Exp Ther 2007, 323:49-60.
15. Manalo D.J., Buehler P.W., Baek J.H., et al. Acellular haemoglobin attenuates hypoxia-inducible factor-1alpha (HIF-1alpha) and its target genes in haemodiluted rats. Biochem J 2008, 414:461-469.
16. Winslow R.M. Current status of oxygen carries ('blood substitutes'): 2006. Vox Sang 2006, 91:102-110.
17. Jia L., Bonaventura C., Bonaventura J., et al. S.nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996, 380:221-226.
18. Cosby K., Partove K.S., Crawford J.H., et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003, 9:1498-1505.
19. Mackenzie C.F., Bucci C. Artificial oxygen carriers for trauma: myth or reality. Hosp Med 2004, 65:562-568.
20. D'Agnillo F., Alayash A.I. Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells. Blood 2001, 98:3315-3323.
21. Vandergrift K.D., Malavalli A., Minn C., et al. Oxidation and haem loss kinetics of Poly(ethylene glycol)-conjugated (MP4): dissociation between in vitro and in vivo oxidation rates. Biochem J 2006, 399:463-471.
22. Boretti F.S., Buehler P.W., D'Agnillo, et al. Sequestration of extracellular hemoglobin within haptoglobin complex decrease it hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest 2009, 119:2271-2280.
23. Buehler P.W., Abraham B., Vallelian F., et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 2009, 113:2578-2586.